Covered recipient · General Payments record
VIKTORIA KAPLAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$68,069.86
- Reported across 1,028 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,031.68 | 154 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $502.73 | 31 |
| Amgen Inc. | $293.78 | 12 |
| ARGENX US, INC. | $245.49 | 11 |
| EMD Serono, Inc. | $239.49 | 15 |
| TG THERAPEUTICS, INC. | $196.24 | 8 |
| Biogen, Inc. | $167.88 | 10 |
| Celgene Corporation | $142.04 | 13 |
| Neurocrine BioSciences, Inc. | $136.47 | 1 |
| Genentech USA, Inc. | $129.08 | 8 |
| GENZYME CORPORATION | $107.27 | 4 |
| SK Life Science, Inc. | $89.28 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $84.98 | 4 |
| EISAI INC. | $76.58 | 3 |
| BANNER LIFE SCIENCES, LLC | $74.76 | 4 |
| Alexion Pharmaceuticals, Inc. | $68.86 | 3 |
| UCB, Inc. | $68.50 | 3 |
| PFIZER INC. | $57.30 | 4 |
| Sandoz Inc. | $54.54 | 2 |
| Axsome Therapeutics, Inc. | $40.24 | 2 |
| Genentech, Inc. | $29.42 | 1 |
| Lilly USA, LLC | $28.51 | 1 |
| E.R. Squibb & Sons, L.L.C. | $23.24 | 1 |
| Kedrion Biopharma, Inc. | $22.50 | 1 |
| JAZZ PHARMACEUTICALS INC. | $22.48 | 1 |
| Lundbeck LLC | $22.24 | 1 |
| ANI Pharmaceuticals, Inc. | $22.15 | 1 |
| Janssen Scientific Affairs, LLC | $21.67 | 1 |
| Neurelis, Inc. | $21.34 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $15.28 | 1 |
| Vanda Pharmaceuticals Inc. | $14.31 | 1 |
| CYCLE PHARMACEUTICALS INC | $13.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (154)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.